ターゲット市場の実像をつかむ
Pharma Must Not Let Its COVID-19 Halo Slip
Biopharma’s accomplishments in tackling the global COVID-19 pandemic, unlike advances within oncology such as cell therapies and checkpoint inhibitors, or functional cures for HIV and hepatitis C, have captured the public’s imagination.